For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240112:nRSL4614Za&default-theme=true
RNS Number : 4614Z Transense Technologies PLC 12 January 2024
12 January 2024
Transense Technologies plc
("Transense" or the "Company")
Director/PDMR shareholding - acquisition of shares
Transense Technologies plc, the provider of specialist sensing solutions and
measurement systems, has been notified that Ryan Maughan, Business Development
Director, on 11 January 2024, purchased 1,800 ordinary shares of 10 pence each
in the Company ("Ordinary Shares") at a price of 98 pence per share.
Accordingly, Ryan Maughan's total beneficial shareholding in the Company has
increased to 31,807 Ordinary Shares, which represents approximately 0.21% of
the Company's current voting rights.
Further details are provided in the forms below in accordance with the
requirements of the UK Market Abuse Regulation.
For further information please visit www.transense.com or contact:
Transense Technologies plc Via Walbrook PR
Nigel Rogers (Executive Chairman)
Melvyn Segal (CFO)
Allenby Capital (Nominated Adviser and Broker) Tel: +44 (0)20 3328 5656
Jeremy Porter / George Payne (Corporate Finance)
Stefano Aquilino / Tony Quirke (Sales & Corporate Broking)
Walbrook PR Tel: +44 (0)20 7933 8780
Tom Cooper/Nick Rome / Joseph Walker Transense@walbrookpr.com
Notes to Editors:
Transense is a developer of specialist wireless sensor systems used to enable
real-time data gathering and monitoring. Products include the patent
protected Surface Acoustic Wave (SAW) sensor technology, used to improve
equipment power, performance, reliability and efficiency; iTrack, Transense's
Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the
world's largest tyre producer, under a ten-year deal in June 2020; and a range
of intelligent tyre monitoring equipment under the Translogik brand. Target
sectors include aerospace, automotive (high performance and off-road) and
complex machine control.
The Group's strategy is to maximise shareholder value through the delivery of
sustained revenue growth from all three principal technologies - SAW, iTrack
and Translogik probes - through leveraging excellence in innovation, know-how
in commercialising technologies, industry partnerships and exposure to global
growth markets.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on
AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.
www.transense.com
For further information please contact transense@walbrookpr.com.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Ryan Maughan
2 Reason for the notification
a) Position/status Business Development Director
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Transense Technologies plc
b) LEI 2138005N52J6KKQ3EY67
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 10 pence each
Identification code GB00BDHDTH21
b) Nature of the transaction Purchase of Ordinary Shares
c) Price and volume Price: 98 pence per share
Volume: 1,800
d) Aggregated information
- Aggregated volume As above
- Price
e) Date of the transaction 11 January 2024
f) Place of the transaction London Stock Exchange, AIM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFLALIILLIS